Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation

DSpace/Manakin Repository

Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation

Citable link to this page

 

 
Title: Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation
Author: Koudriavtseva, Tatiana; Mainero, Caterina

Note: Order does not necessarily reflect citation order of authors.

Citation: Koudriavtseva, Tatiana, and Caterina Mainero. 2016. “Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation.” Frontiers in Human Neuroscience 10 (1): 226. doi:10.3389/fnhum.2016.00226. http://dx.doi.org/10.3389/fnhum.2016.00226.
Full Text & Related Files:
Abstract:
Published Version: doi:10.3389/fnhum.2016.00226
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865512/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:27320314
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters